Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-056298)

Filing Details

Accession Number:: 0001209191-18-056298
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-26 16:16:06
Reporting Period:: 2018-10-26

Accepted Time:: 2018-10-26 16:16:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1445283	Proteostasis Therapeutics Inc.	PTI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273885	M Franklin Berger	C/O Proteostasis Therapeutics, Inc. 80 Guest Street, Suite 500 Boston MA 02135		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-26	40,000	$6.75	40,000	No	4	P	Indirect	By: FMB Research

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By: FMB Research

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	266,162	Direct